GFAP and Alzheimer disease: In this present observational study, we examine the diagnostic accuracy of p-tau217, and further blood biomarkers including p-tau231, p-tau181, Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP), in detecting AD in DS.